Redwood Grove Capital LLC boosted its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN – Free Report) by 10.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 147,705 shares of the construction company’s stock after purchasing an additional 14,495 shares during the period. Aspen Aerogels comprises approximately 1.1% of Redwood Grove Capital LLC’s holdings, making the stock its 22nd largest holding. Redwood Grove Capital LLC owned about 0.18% of Aspen Aerogels worth $4,090,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. Oppenheimer & Co. Inc. increased its holdings in Aspen Aerogels by 167.2% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company’s stock valued at $2,839,000 after purchasing an additional 64,154 shares during the period. Penserra Capital Management LLC purchased a new position in Aspen Aerogels during the 3rd quarter valued at about $1,342,000. Dakota Wealth Management purchased a new position in shares of Aspen Aerogels during the 3rd quarter worth approximately $986,000. Rice Hall James & Associates LLC grew its holdings in shares of Aspen Aerogels by 19.9% during the 3rd quarter. Rice Hall James & Associates LLC now owns 535,113 shares of the construction company’s stock worth $14,817,000 after acquiring an additional 88,711 shares during the period. Finally, Comerica Bank purchased a new position in shares of Aspen Aerogels during the 1st quarter worth approximately $1,992,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.
Analyst Ratings Changes
A number of research firms have weighed in on ASPN. HC Wainwright reiterated a “buy” rating and set a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. Benchmark reiterated a “buy” rating and set a $14.00 target price on shares of Aspen Aerogels in a report on Thursday, August 8th. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Wednesday, November 13th. Roth Mkm reduced their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. Finally, Barclays reduced their target price on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday, November 12th. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $28.70.
Insider Activity at Aspen Aerogels
In related news, CEO Donald R. Young sold 63,355 shares of the company’s stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the transaction, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This represents a 11.58 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 4.30% of the stock is currently owned by insiders.
Aspen Aerogels Stock Performance
ASPN stock opened at $14.34 on Thursday. The stock has a market capitalization of $1.18 billion, a PE ratio of 1,434.00 and a beta of 2.12. Aspen Aerogels, Inc. has a 12-month low of $10.36 and a 12-month high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The stock’s 50 day simple moving average is $19.18 and its 200 day simple moving average is $23.66.
Aspen Aerogels Profile
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Further Reading
- Five stocks we like better than Aspen Aerogels
- What is Short Interest? How to Use It
- Tesla Poised to Hit Record Highs This Holiday Season
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- The Salesforce Rally is Just Getting Started: Here’s Why
- Overbought Stocks Explained: Should You Trade Them?
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Want to see what other hedge funds are holding ASPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aspen Aerogels, Inc. (NYSE:ASPN – Free Report).
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.